Treating Preterm Infants at Risk for Chronic Lung Disease with Dexamethasone Leads to an Impaired Quality of General Movements

Publisher： Karger

E-ISSN： 1661-7819|82|3|155-158

ISSN： 1661-7800

Source： Neonatology, Vol.82, Iss.3, 2002-10, pp. : 155-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Quality of General Movements after Treatment with Low-Dose Dexamethasone in Preterm Infants at Risk of Bronchopulmonary Dysplasia

By  

Neonatology, Vol. 106, Iss. 3, 2014-07 ,pp. : 222-228

Karger

Access to resources Recommend Favorite

Early (4–7 Days of Age) Dexamethasone Therapy for Prevention of Chronic Lung Disease in Preterm Infants

By  

Neonatology, Vol. 76, Iss. 5, 1999-10 ,pp. : 283-290

Karger

Access to resources Recommend Favorite

Current Dilemmas in Postnatal Steroid Therapy for Chronic Lung Disease in Preterm Infants

By  

Neonatology, Vol. 84, Iss. 1, 2003-07 ,pp. : 96-100

Karger

Access to resources Recommend Favorite

Oxidation Products of Uric Acid and Ascorbic Acid in Preterm Infants with Chronic Lung Disease

By  

Neonatology, Vol. 73, Iss. 1, 1997-12 ,pp. : 24-33

Karger

Access to resources Recommend Favorite

Decreased Use of Postnatal Corticosteroids in Extremely Preterm Infants without Increasing Chronic Lung Disease

By  

Neonatology, Vol. 95, Iss. 2, 2008-09 ,pp. : 172-178

Karger

Access to resources Recommend Favorite